BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 21528673)

  • 21. Combination of serum hCG beta and p53 tissue expression defines distinct subgroups of serous ovarian carcinoma.
    Vartiainen J; Lassus H; Lehtovirta P; Finne P; Alfthan H; Butzow R; Stenman UH
    Int J Cancer; 2008 May; 122(9):2125-9. PubMed ID: 18098286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TPA, TATI, CEA, AFP, beta-HCG, PSA, SCC, and CA 19-9 for monitoring transitional cell carcinoma of the bladder.
    Pectasides D; Bafaloucos D; Antoniou F; Gogou L; Economides N; Varthalitis J; Dimitriades M; Kosmidis P; Athanassiou A
    Am J Clin Oncol; 1996 Jun; 19(3):271-7. PubMed ID: 8638540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The beta-hCG subunit, CA 125 and CA 19-9 antigen in the women with non-trophoblastic malignancy of genital tract].
    Piela A; Lewandowska M
    Ginekol Pol; 2001 Aug; 72(8):629-33. PubMed ID: 11599248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differentiating tubal abortion from viable ectopic pregnancy with serum CA-125 and beta-human chorionic gonadotropin determinations.
    Predanic M
    Fertil Steril; 2000 Mar; 73(3):522-5. PubMed ID: 10689006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A rare case of β-hCG production by a solitary fibrous tumor of the pleura.
    Kugasia IR; Alkayem M; Patel JB
    Am J Case Rep; 2014 Nov; 15():518-22. PubMed ID: 25420430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum HCG beta, CA 72-4 and CEA are independent prognostic factors in colorectal cancer.
    Louhimo J; Carpelan-Holmström M; Alfthan H; Stenman UH; Järvinen HJ; Haglund C
    Int J Cancer; 2002 Oct; 101(6):545-8. PubMed ID: 12237895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening of persistent trophoblastic disease with various serum markers.
    Mungan T; Kuşçu E; Uğur M; Dabakoğlu T; Senses E; Cobanoğlu O
    Eur J Gynaecol Oncol; 1998; 19(5):495-7. PubMed ID: 9863923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of urinary beta-core fragment of human chorionic gonadotropin as a new tumor marker of lung cancer.
    Yoshimura M; Nishimura R; Murotani A; Miyamoto Y; Nakagawa T; Hasegawa K; Koizumi T; Shii K; Baba S; Tsubota N
    Cancer; 1994 Jun; 73(11):2745-52. PubMed ID: 7514953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Case report: elevated serum beta human chorionic gonadotropin in a woman with osteosarcoma.
    Tuy BE; Obafemi AA; Beebe KS; Patterson FR
    Clin Orthop Relat Res; 2008 Apr; 466(4):997-1001. PubMed ID: 18288544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Significance of serum beta-hCG as a tumor marker for stomach carcinoma].
    Rau B; Below C; Haensch W; Liebrich W; von Schilling C; Schlag PM
    Langenbecks Arch Chir; 1995; 380(6):359-64. PubMed ID: 8559007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination assay of urinary beta-core fragment of human chorionic gonadotropin with serum tumor markers in gynecologic cancers.
    Kinugasa M; Nishimura R; Koizumi T; Morisue K; Higashida T; Natazuka T; Nakagawa T; Isobe T; Baba S; Hasegawa K
    Jpn J Cancer Res; 1995 Aug; 86(8):783-9. PubMed ID: 7559103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Choriogonadotropin positive seminoma-a clinicopathological and molecular genetic study of 15 cases.
    Hes O; Pivovarcikova K; Stehlik J; Martinek P; Vanecek T; Bauleth K; Dolejsova O; Petersson F; Hora M; Perez Montiel D; Peckova K; Branzovsky J; Slouka D; Vodicka J; Kokoskova B; Matej R; Michal M
    Ann Diagn Pathol; 2014 Apr; 18(2):89-94. PubMed ID: 24480432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum gonadotropin levels in patients with germ-cell tumors of the testis: interrelations, possible cross-reactions and interpretation of beta-HCG level.
    Kovcin VN; Jelić SB; Ivanović SM; Babović NL
    Int J Biol Markers; 1997; 12(2):55-60. PubMed ID: 9342633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Independent prognostic value of preoperative serum markers CA 242, specific tissue polypeptide antigen and human chorionic gonadotrophin beta, but not of carcinoembryonic antigen or tissue polypeptide antigen in colorectal cancer.
    Carpelan-Holmström M; Haglund C; Lundin J; Alfthan H; Stenman UH; Roberts PJ
    Br J Cancer; 1996 Sep; 74(6):925-9. PubMed ID: 8826859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of repeated serum CA 125 measurements in first trimester pregnancy.
    Schmidt T; Rein DT; Foth D; Eibach HW; Kurbacher CM; Mallmann P; Römer T
    Eur J Obstet Gynecol Reprod Biol; 2001 Aug; 97(2):168-73. PubMed ID: 11451543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A preliminary investigation of Beta-hCG expression in patients with osteosarcoma.
    Masrouha KZ; Khattab R; Tawil A; Abdallah A; Saghieh S; Haidar R; Abboud M; Khoury NJ
    J Bone Joint Surg Br; 2012 Mar; 94(3):419-24. PubMed ID: 22371553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human chorionic gonadotropin (hCG) beta-core fragment is produced by degradation of hCG or free hCG beta in gestational trophoblastic tumors: a possible marker for early detection of persistent postmolar gestational trophoblastic disease.
    Okamoto T; Matsuo K; Niu R; Osawa M; Suzuki H
    J Endocrinol; 2001 Dec; 171(3):435-43. PubMed ID: 11739009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer antigen 125, tissue polypeptide antigen, carcinoembryonic antigen, and beta-chain human chorionic gonadotropin as serum markers of epithelial ovarian carcinoma.
    Panza N; Pacilio G; Campanella L; Peluso G; Battista C; Amoriello A; Utech W; Vacca C; Lombardi G
    Cancer; 1988 Jan; 61(1):76-83. PubMed ID: 2446734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Testicular seminoma with human chorionic gonadotropin production.
    Hori K; Uematsu K; Yasoshima H; Yamada A; Sakurai K; Ohya M
    Pathol Int; 1997 Sep; 47(9):592-9. PubMed ID: 9311009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experience of discordant beta hCG results by different assays in the management of non-seminomatous germ cell tumours of the testis.
    Summers J; Raggatt P; Pratt J; Williams MV
    Clin Oncol (R Coll Radiol); 1999; 11(6):388-92. PubMed ID: 10663328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.